Literature DB >> 1518113

Tuberculosis and HIV infection in sub-Saharan Africa.

K M De Cock1, B Soro, I M Coulibaly, S B Lucas.   

Abstract

OBJECTIVES: To review the epidemiologic, clinical, and pathological characteristics and the public health implications of human immunodeficiency virus (HIV)-associated tuberculosis in sub-Saharan Africa. DATA SOURCES: Published medical literature (English and French) and proceedings of international and African conferences on the acquired immunodeficiency syndrome (AIDS). STUDY SELECTION: Selection by the authors of articles most pertinent to HIV infection and tuberculosis in Africa and internationally. DATA EXTRACTION: Direct reporting of quantitative data (eg, HIV seroprevalence levels) and of qualitative descriptions and conclusions from selected literature. DATA SYNTHESIS: High rates (20% to 67%) of HIV infection in patients with tuberculosis have been reported from East, West, Central, and Southern Africa. An increase in tuberculosis cases has been reported at the same time as the emergence of AIDS in several countries. Autopsies in Abidjan, Ivory Coast (Côte d'Ivoire), have shown tuberculosis as the most frequent opportunistic infection in patients dying of AIDS. Clinical differences in patients with tuberculosis who were HIV-positive and HIV-negative are reviewed, the most important being a greatly increased mortality rate in HIV-associated disease. Access to HIV testing is required for firm diagnosis, for clinical care and counseling, and for public health surveillance.
CONCLUSIONS: The epidemiology of tuberculosis has been profoundly influenced by the epidemic of HIV infection in sub-Saharan Africa. Greatly increased human and material resources are required for this neglected problem in international health.

Entities:  

Mesh:

Year:  1992        PMID: 1518113     DOI: 10.1001/jama.268.12.1581

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  74 in total

Review 1.  Tuberculous meningitis.

Authors:  G Thwaites; T T Chau; N T Mai; F Drobniewski; K McAdam; J Farrar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

Review 2.  BCG and tuberculosis.

Authors:  M J Bannon
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

Review 3.  Scientific surveillance and the control of AIDS: a call for open debate.

Authors:  G T Stewart
Journal:  Health Care Anal       Date:  1994-11

4.  Tuberculosis among Africans living in the United States, 2000-2009.

Authors:  Bisrat K Abraham; Carla A Winston; Elvin Magee; Roque Miramontes
Journal:  J Immigr Minor Health       Date:  2013-04

Review 5.  Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics.

Authors:  Simon J Tsiouris; Neel R Gandhi; Wafaa M El-Sadr; Gerald Friedland
Journal:  MedGenMed       Date:  2007-09-25

Review 6.  HIV and tuberculosis coinfection: inextricably linked liaison.

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

7.  Retinal findings in Malawian patients with AIDS.

Authors:  S Lewallen; J Kumwenda; D Maher; A D Harries
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

8.  DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania.

Authors:  Z H Yang; I Mtoni; M Chonde; M Mwasekaga; K Fuursted; D S Askgård; J Bennedsen; P E de Haas; D van Soolingen; J D van Embden
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Pulmonary tuberculosis in Harare, Zimbabwe: analysis by spoligotyping.

Authors:  R S Heyderman; M Goyal; P Roberts; S Ushewokunze; S Zizhou; B G Marshall; R Makombe; J D Van Embden; P R Mason; R J Shaw
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

Review 10.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.